Oncostatin M up-regulates the ER chaperone Grp78/BiP in liver cells

Biochemical Pharmacology

Volumn 80, Issue 12, 2010, Pages 2066-2073

  Vollmer, Stefan ^a   Haan, Claude ^a   Behrmann, Iris ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

Cytokine signal transduction; Cytokines; Grp78 BiP; Jak STAT; MAP kinases; Oncostatin M

Indexed keywords

GAMMA INTERFERON; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; INITIATION FACTOR 2ALPHA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; ONCOSTATIN M; TUMOR NECROSIS FACTOR ALPHA; X BOX BINDING PROTEIN 1;

ARTICLE; CELLULAR STRESS RESPONSE; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA SPLICING; SIGNAL TRANSDUCTION;

CELL LINE; ENDOPLASMIC RETICULUM; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-6; JANUS KINASES; LIVER; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; ONCOSTATIN M; ORGAN SPECIFICITY; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 78049437095     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.07.015     Document Type: Article

References (49)

1. Tanaka M., Miyajima A. Oncostatin M, a multifunctional cytokine. Reviews of Physiology, Biochemistry and Pharmacology 2003, 149:39-52.
2. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Müller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. The Biochemical Journal 2003, 374:1-20.
3. Böing I., Stross C., Radtke S., Lippok B.E., Heinrich P.C., Hermanns H.M. Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases. Cellular Signalling 2006, 18:50-61.
4. Vasse M., Pourtau J., Trochon V., Muraine M., Vannier J.P., Lu H., et al. Oncostatin M induces angiogenesis in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology 1999, 19:1835-1842.
5. Nakamura K., Nonaka H., Saito H., Tanaka M., Miyajima A. Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 2004, 39:635-644.
6. Hamada T., Sato A., Hirano T., Yamamoto T., Son G., Onodera M., et al. Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats. American Journal of Pathology 2007, 171:872-881.
7. Shiu R.P., Pouyssegur J., Pastan I. Glucose depletion accounts for the induction of two transformation-sensitive membrane proteinsin Rous sarcoma virus-transformed chick embryo fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 1977, 74:3840-3844.
8. Haas I., Wabl M. Immunoglobulin heavy chain binding protein. Nature 1983, 306:387-389.
9. Daugaard M., Rohde M., Jaattela M. The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Letters 2007, 581:3702-3710.
10. Ni M., Zhou H., Wey S., Baumeister P., Lee A.S. Regulation of PERK signaling and leukemic cell survival by a novel cytosolic isoform of the UPR regulator GRP78/BiP. PLoS One 2009, 4:e6868.
11. Panayi G.S., Corrigall V.M. BiP regulates autoimmune inflammation and tissue damage. Autoimmunity Reviews 2006, 5:140-142.
12. Zhang Y., Liu R., Ni M., Gill P., Lee A.S. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. The Journal of Biological Chemistry 2010, 285:15065-15075.
13. Dudek J., Benedix J., Cappel S., Greiner M., Jalal C., Müller L., et al. Functions and pathologies of BiP and its interaction partners. Cellular and Molecular Life Sciences 2009, 66:1556-1569.
14. Ni M., Lee A.S. ER chaperones in mammalian development and human diseases. FEBS Letters 2007, 581:3641-3651.
15. 2+ depletion. A comparative analysis with A23187 and the endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin. The Journal of Biological Chemistry 1993, 268:12003-12009.
16. Olden K., Pratt R.M., Jaworski C., Yamada K.M. Evidence for role of glycoprotein carbohydrates in membrane transport: specific inhibition by tunicamycin. Proceedings of the National Academy of Sciences of the United States of America 1979, 76:791-795.
17. Lee A.S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Research 2007, 67:3496-3499.
18. Rebouissou S., Amessou M., Couchy G., Poussin K., Imbeaud S., Pilati C., et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009, 457:200-204.
19. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science (New York, NY) 2007, 317:121-124.
20. Chen D.-C., Kawakami M., He J., Sakamoto T., Okada Y. Up-regulation of glucose regulated protein 78 after burn injury. Nihon Kyukyu Igakukai Zasshi 1999, 10:623-624.
21. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochemical Journal 1990, 265:621.
22. Richards C.D., Brown T.J., Shoyab M., Baumann H., Gauldie J. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. Journal of Immunology 1992, 148:1731-1736.
23. Ikeda M., Sugiyama K., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., et al. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochemical and Biophysical Research Communications 1998, 245:549-553.
24. Haan C., Behrmann I. A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. Journal of Immunological Methods 2007, 318:11-19.
25. Song M.S., Park Y.K., Lee J.H., Park K. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. Cancer Research 2001, 61:8322-8330.
26. Tardif K.D. Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response. Journal of Biological Chemistry 2004, 279:17158-17164.
27. Chen Y.G., Ashok B.T., Liu X., Garikapaty V.P., Mittelman A., Tiwari R.K. Induction of heat shock protein gp96 by immune cytokines. Cell Stress & Chaperones 2003, 8:242-248.
28. Bobrovnikova-Marjon E.V., Marjon P.L., Barbash O., Vander Jagt D.L., Abcouwer S.F. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Cancer Research 2004, 64:4858-4869.
29. Stein I., Neeman M., Shweiki D., Itin A., Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Molecular and Cellular Biology 1995, 15:5363-5368.
30. Vollmer S., Kappler V., Kaczor J., Flügel D., Rolvering C., Kato N., et al. Hypoxia-inducible factor 1alpha is up-regulated by oncostatin M and participates in oncostatin M signaling. Hepatology 2009, 50:253-260.
31. Haan C., Kreis S., Margue C., Behrmann I. Jaks and cytokine receptors-an intimate relationship. Biochemical Pharmacology 2006, 72:1538-1546.
32. Costa-Pereira A.P., Tininini S., Strobl B., Alonzi T., Schlaak J.F., Is'harc H., et al. Mutational switch of an IL-6 response to an interferon-gamma-like response. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8043-8047.
33. Feldman D.E., Chauhan V., Koong A.C. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Molecular Cancer Research 2005, 3:597-605.
34. Zhang L.J., Chen S., Wu P., Hu C.S., Thorne R.F., Luo C.M., et al. Inhibition of MEK blocks GRP78 up-regulation and enhances apoptosis induced by ER stress in gastric cancer cells. Cancer Letters 2009, 274:40-46.
35. Hermanns H.M., Radtke S., Schaper F., Heinrich P.C., Behrmann I. Non-redundant Signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to the oncostatin m receptor. Journal of Biological Chemistry 2000, 275:40742-40748.
36. Nishikawa T., Hagihara K., Serada S., Isobe T., Matsumura A., Song J., et al. Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression. Journal of Immunology 2008, 180:3492-3501.
37. Leu J.I., Crissey M.A., Leu J.P., Ciliberto G., Taub R. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Molecular and Cellular Biology 2001, 21:414-424.
38. Jain S., Li Y., Patil S., Kumar A. HNF-1alpha plays an important role in IL-6-induced expression of the human angiotensinogen gene. American Journal of Physiology: Cell Physiology 2007, 293:C401-C410.
39. Wang Z., Burke P.A. Effects of hepatocyte nuclear factor-4alpha on the regulation of the hepatic acute phase response. Journal of Molecular Biology 2007, 371:323-335.
40. Healy S.J., Gorman A.M., Mousavi-Shafaei P., Gupta S., Samali A. Targeting the endoplasmic reticulum-stress response as an anticancer strategy. European Journal of Pharmacology 2009, 625:234-246.
41. Dong D., Ni M., Li J., Xiong S., Ye W., Virrey J.J., et al. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Research 2008, 68:498-505.
42. Fu Y., Wey S., Wang M., Ye R., Liao C.P., Roy-Burman P., et al. Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19444-19449.
43. Shuda M., Kondoh N., Imazeki N., Tanaka K., Okada T., Mori K., et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. Journal of Hepatology 2003, 38:605-614.
44. Al-Rawashdeh F.Y., Scriven P., Cameron I.C., Vergani P.V., Wyld L. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma. European Journal of Gastroenterology and Hepatology 2010.
45. Hsu J.L., Chiang P.C., Guh J.H. Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78. Naunyn-Schmiedeberg's Archives of Pharmacology 2009, 380:373-382.
46. Llovet J.M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.F., et al. Sorafenib in advanced hepatocellular carcinoma. The New England Journal of Medicine 2008, 359:378-390.
47. Keating G.M., Santoro A. Sorafenib: a review of its use in advanced hepatocellular carcinoma. Drugs 2009, 69:223-240.
48. Rahmani M., Davis E.M., Crabtree T.R., Habibi J.R., Nguyen T.K., Dent P., et al. The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress. Molecular and Cellular Biology 2007, 27:5499-5513.
49. Chiou J.F., Tai C.J., Huang M.T., Wei P.L., Wang Y.H., An J., et al. Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma. Annals of Surgical Oncology 2010, 17:603-612.